Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
UK SPAC Ashington Innovation has announced today it will IPO on the main market of the London Stock Exchange.
The company specializes in the fintech and deep tech sectors and has raised £809,437 in gross proceeds – consisting of 26,981,233 ordinary shares at 3 pence per share.
Subject to admission to the standard listing segment of the LSE, Ashington Innovation said it will have 61,397,900 shares in issue, valuing it at around £1.84m.
READCheche Technology Inc., China’s leading auto insurance technology platform, announced the release of its EV 2.0 Upgrade Solution featuring the Sky Dome Risk Management Platform. This comprehensive business intelligence platform synthesizes various categories and levels of data, augmented by machine learning, to drive superior capabilities in underwriting, pricing, claims management, and group fraud detections.
Cheche Technology announced on January 30, 2023, that it had entered into a definitive business combination agreement with Prime Impact Acquisition I (“Prime Impact”) (NYSE: PIAI).
READ
Plenty of stocks are rebounding this month as the market broadly rallies on signs that the age of rate hikes is ending, but DraftKings (NASDAQ:DKNG) is on an uncommonly sharp trajectory among recent de-SPACs. The digital gaming and betting platform, which combined with Diamond Eagle in April 2020, opened 2023 trading at $11.63 – nearly...
At the SPAC of Dawn Public companies of all stripes tend to bury news ahead of holidays and SPACs are no different. Four SPACs have announced their intent to liquidate since market close on Friday and three of these had previously agreed to business combinations. The last cluster of broken deals and liquidated SPACs this...
Terms Tracker for the Week Ending November 17, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. SPACs saw another IPO this week from Global Lights Acquisition Corp. (Nasdaq: GLACU), the $60 million offering from Chardan, which had an impressive first day...
Bellevue Life Sciences (NASDAQ:BLAC) has entered into a definitive agreement to combine with Korean healthcare holding company OSR for undisclosed compensation. Seoul-based OSR is a conglomerate of several biotech firms advancing drug candidates as well as a medical device distributor. Transaction Overview Bellevue has about $36.4 million in its current trust having seen 49.7% redeemed...
At the SPAC of Dawn A largely positive week is coming to end with a summit that appears to have brought an autumn chill to simmering tensions between the US and China. Chinese President Xi Jinping and US President Joe Biden each offered olive branches and offhand “dictator” comments aside, both appeared to want to...
